Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 10, 2020

SELL
$0.96 - $2.94 $24,000 - $73,500
-25,000 Closed
0 $0
Q3 2019

Oct 10, 2019

BUY
$0.58 - $3.01 $14,499 - $75,250
25,000 New
25,000 $63,000
Q3 2019

Oct 04, 2019

SELL
$0.58 - $3.01 $14,499 - $75,250
-25,000 Closed
0 $0
Q2 2019

Jul 10, 2019

BUY
$1.47 - $3.16 $22,050 - $47,400
15,000 Added 150.0%
25,000 $42,000
Q1 2019

Apr 08, 2019

BUY
$2.56 - $4.48 $25,600 - $44,800
10,000 New
10,000 $26,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $4.09M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.